Akt and Hippo Pathways in Ewing's Sarcoma Tumors and Their Prognostic Significance

Atif A Ahmed1, Malak Abedalthagafi1, Ahmed E Anwar2

  • 11. Department of Pathology, King Fahad Medical City, Riyadh, Saudi Arabia.

Journal of Cancer
|September 15, 2015
PubMed
Abstract

Insights

High Akt protein expression in Ewing's sarcoma correlates with poorer survival. Yap, mTOR, and Erk showed variable expression but no survival link, suggesting Akt as a therapeutic target.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cancer Research

Background:

  • Ewing's sarcoma is an aggressive pediatric and young adult cancer with high mortality due to metastasis.
  • Intracellular signaling molecules Yap, Akt, mTOR, and Erk regulate tumor cell proliferation.

Purpose of the Study:

  • To investigate the immunohistochemical expression of Yap, Akt, mTOR, and Erk in Ewing's sarcoma.
  • To correlate protein expression with patient survival outcomes.

Main Methods:

  • Analyzed 36 Ewing's sarcoma tumor samples from adult and pediatric patients.
  • Utilized immunohistochemistry to assess Yap, Akt, mTOR, and Erk protein expression.
  • Collected clinical data including age, sex, tumor characteristics, and survival data.

Main Results:

  • Variable expression of Yap, Akt, mTOR, and Erk was observed.
  • High Akt expression was found in 53% of tumors and linked to worse overall and disease-free survival (p<0.05).
  • Yap, mTOR, and Erk expression levels did not correlate with survival differences.

Conclusions:

  • Akt protein expression is a significant prognostic marker in Ewing's sarcoma.
  • Targeted therapy against Akt may improve outcomes for patients with Ewing's sarcoma.
  • Further research with larger cohorts is necessary to validate these findings.

Related Concept Videos

mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
5.1K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

1.7K
Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
4.0K
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
6.4K
Tumor Progression02:07

Tumor Progression

Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
7.9K
Tumor Progression02:07

Tumor Progression

3.6K